# Novo Nordisk says it will seek federal approval to expand the use of its Ozempic and Rybelsus pills.

*biotech · news · 2026-04-24 · Pittsburgh Tribune-Review*

## Key points

- Novo Nordisk will seek FDA approval to expand Ozempic and Rybelsus use for minors.
- No oral GLP-1 drugs are FDA approved for kids and teenagers with Type 2 diabetes.
- A stage 3 trial showed Ozempic and Rybelsus pills are effective and have limited side effects.
- Rybelsus exists only as a pill, while Ozempic is available in both injection and soon pill form.

**Companies:** Novo Nordisk
**Countries:** Denmark, United States

[Read the full story on Pittsburgh Tribune-Review](https://triblive.com/news/world/drugmaker-to-seek-fda-approval-of-ozempic-pill-for-diabetic-kids/)

---

Canonical: https://newsio.io/n/20c46b39-cc9c-4186-86e5-6fac9dccc603/novo-nordisk-says-it-will-seek-federal-approval-to-expand-the-use-of-its-ozempic
Summarized by Newsio from Pittsburgh Tribune-Review. https://newsio.io/how-it-works